D
CRISPR Therapeutics AG CRSP
$54.13 -$0.19-0.35% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -75.99% -77.61% -138.43% 32.23% 36.09%
Total Depreciation and Amortization -2.75% -2.33% -2.91% -7.05% -6.58%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 173.65% 2.23% -28.42% -28.21% -38.00%
Change in Net Operating Assets -137.91% 103.14% 180.72% -9.97% 290.03%
Cash from Operations -166.73% -92.24% 45.17% 31.99% 64.50%
Capital Expenditure 81.42% 80.57% 79.93% 84.02% 77.24%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 97.36% -221.01% -172.52% -257.49% -167.99%
Cash from Investing 96.99% -227.30% -174.87% -266.72% -174.92%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -88.64% -89.78% 430.53% 1,252.95% 771.32%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -88.62% -89.91% 429.78% 1,251.17% 770.15%
Foreign Exchange rate Adjustments 2,625.00% 3.33% -128.77% 0.00% -94.67%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -838.26% -230.16% -151.58% -1,133.23% 169.76%